Identification of M(pro) inhibitors of SARS-CoV-2 using structure based computational drug repurposing

The recent outbreak of COVID-19, caused by the novel pathogen SARS-coronavirus 2 (SARS-CoV-2) is a severe health emergency. In this pandemic, drug repurposing seems to be the most promising alternative to identify effective therapeutic agents for immediate treatment of infected patients. The present...

Descripción completa

Detalles Bibliográficos
Autores principales: Nath, Virendra, Rohini, A., Kumar, Vipin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483991/
https://www.ncbi.nlm.nih.gov/pubmed/34611467
http://dx.doi.org/10.1016/j.bcab.2021.102178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483991/
https://www.ncbi.nlm.nih.gov/pubmed/34611467
http://dx.doi.org/10.1016/j.bcab.2021.102178

Ejemplares similares